The role of hydroxyurea in sickle cell disease

Br J Haematol. 2003 Jan;120(2):177-86. doi: 10.1046/j.1365-2141.2003.03849.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / drug therapy*
  • Antisickling Agents / adverse effects
  • Antisickling Agents / therapeutic use*
  • Cell Communication
  • Child
  • Child, Preschool
  • Endothelium, Vascular / pathology
  • Erythrocyte Deformability / drug effects
  • Erythrocytes / pathology
  • Female
  • Follow-Up Studies
  • Hemoglobin, Sickle / metabolism
  • Humans
  • Hydroxyurea / adverse effects
  • Hydroxyurea / therapeutic use*
  • Infant
  • Male
  • Middle Aged
  • Neoplasms, Second Primary / chemically induced
  • Pregnancy
  • Randomized Controlled Trials as Topic
  • Teratogens
  • beta-Thalassemia / drug therapy

Substances

  • Antisickling Agents
  • Hemoglobin, Sickle
  • Teratogens
  • Hydroxyurea